Literature DB >> 28945920

Human podocytes express functional thermosensitive TRPV channels.

Lídia Ambrus1, Balázs Kelemen1, Tamás Szabó2, Tamás Bíró1,3, Balázs István Tóth1.   

Abstract

BACKGROUND AND
PURPOSE: Heat-sensitive transient receptor potential vanilloid (TRPV) channels are expressed in various epithelial tissues regulating, among else, barrier functions. Their expression is well established in the distal nephron; however, we have no data about their presence in podocytes. As podocytes are indispensable in the formation of the glomerular filtration barrier, we investigated the presence and function of Ca2+ -permeable TRPV1-4 channels in human podocyte cultures. EXPERIMENTAL APPROACH: Expression of TRPV1-4 channels was investigated at protein (immunocytochemistry, Western blot) and mRNA (Q-PCR) level in a conditionally immortalized human podocyte cell line. Channel function was assessed by measuring intracellular Ca2+ concentration using Flou-4 Ca2+ -indicator dye and patch clamp electrophysiology upon applying various activators and inhibitors. KEY
RESULTS: Thermosensitive TRP channels were expressed in podocytes. The TRPV1-specific agonists capsaicin and resiniferatoxin did not affect the intracellular Ca2+ concentration. Cannabidiol, an activator of TRPV2 and TRPV4 channels, induced moderate Ca2+ -influxes, inhibited by both tranilast and HC067047, blockers of TRPV2 and TRPV4 channels respectively. The TRPV4-specific agonists GSK1016790A and 4α-phorbol 12,13-didecanoate induced robust Ca2+ -signals which were abolished by HC067047. Non-specific agonists of TRPV3 channels induced marked Ca2+ transients. However, TRPV3 channel blockers, ruthenium red and isopentenyl diphosphate only partly inhibited the responses and TRPV3 silencing was ineffective suggesting remarkable off-target effects of the compounds. CONCLUSION AND IMPLICATIONS: Our results indicate the functional presence of TRPV4 and other thermosensitive TRPV channels in human podocytes and raise the possibility of their involvement in the regulation of glomerular filtration barrier.
© 2017 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28945920      PMCID: PMC5715976          DOI: 10.1111/bph.14052

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  79 in total

1.  OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity.

Authors:  R Strotmann; C Harteneck; K Nunnenmacher; G Schultz; T D Plant
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

2.  TRPV1b, a functional human vanilloid receptor splice variant.

Authors:  Gang Lu; Dorian Henderson; Lieju Liu; Peter H Reinhart; Sidney A Simon
Journal:  Mol Pharmacol       Date:  2005-01-11       Impact factor: 4.436

3.  Functional transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 channels along different segments of the renal vasculature.

Authors:  L Chen; M Kaßmann; M Sendeski; D Tsvetkov; L Marko; L Michalick; M Riehle; W B Liedtke; W M Kuebler; C Harteneck; M Tepel; A Patzak; M Gollasch
Journal:  Acta Physiol (Oxf)       Date:  2014-08-21       Impact factor: 6.311

Review 4.  Polycystins and partners: proposed role in mechanosensitivity.

Authors:  Kevin Retailleau; Fabrice Duprat
Journal:  J Physiol       Date:  2014-03-31       Impact factor: 5.182

Review 5.  TRP channels in lower urinary tract dysfunction.

Authors:  J Franken; P Uvin; D De Ridder; T Voets
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

6.  Inhibition of proliferation of MCF-7 breast cancer cells by a blocker of Ca(2+)-permeable channel.

Authors:  L Nie; Y Oishi; I Doi; H Shibata; I Kojima
Journal:  Cell Calcium       Date:  1997-08       Impact factor: 6.817

Review 7.  Targeting the podocyte cytoskeleton: from pathogenesis to therapy in proteinuric kidney disease.

Authors:  Xuefei Tian; Shuta Ishibe
Journal:  Nephrol Dial Transplant       Date:  2016-03-10       Impact factor: 5.992

8.  Molecular determinants of vanilloid sensitivity in TRPV1.

Authors:  Narender R Gavva; Lana Klionsky; Yusheng Qu; Licheng Shi; Rami Tamir; Steve Edenson; T J Zhang; Vellarkad N Viswanadhan; Attila Toth; Larry V Pearce; Todd W Vanderah; Frank Porreca; Peter M Blumberg; Jack Lile; Yax Sun; Ken Wild; Jean-Claude Louis; James J S Treanor
Journal:  J Biol Chem       Date:  2004-03-02       Impact factor: 5.157

Review 9.  The role of transient receptor potential channels in kidney disease.

Authors:  Titia E Woudenberg-Vrenken; René J M Bindels; Joost G J Hoenderop
Journal:  Nat Rev Nephrol       Date:  2009-06-23       Impact factor: 28.314

Review 10.  The podocyte as a target for therapies--new and old.

Authors:  Peter W Mathieson
Journal:  Nat Rev Nephrol       Date:  2011-11-01       Impact factor: 28.314

View more
  6 in total

Review 1.  Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases.

Authors:  Juan Lorenzo Pablo; Anna Greka
Journal:  Trends Pharmacol Sci       Date:  2019-11-05       Impact factor: 14.819

2.  Human podocytes express functional thermosensitive TRPV channels.

Authors:  Lídia Ambrus; Balázs Kelemen; Tamás Szabó; Tamás Bíró; Balázs István Tóth
Journal:  Br J Pharmacol       Date:  2017-11-02       Impact factor: 8.739

3.  Phagocytosis depends on TRPV2-mediated calcium influx and requires TRPV2 in lipids rafts: alteration in macrophages from patients with cystic fibrosis.

Authors:  Manuella Lévêque; Aubin Penna; Sophie Le Trionnaire; Chantal Belleguic; Benoît Desrues; Graziella Brinchault; Stéphane Jouneau; Dominique Lagadic-Gossmann; Corinne Martin-Chouly
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

4.  Molecular and Functional Study of Transient Receptor Potential Vanilloid 1-4 at the Rat and Human Blood-Brain Barrier Reveals Interspecies Differences.

Authors:  Huilong Luo; Bruno Saubamea; Stéphanie Chasseigneaux; Véronique Cochois; Maria Smirnova; Fabienne Glacial; Nicolas Perrière; Catarina Chaves; Salvatore Cisternino; Xavier Declèves
Journal:  Front Cell Dev Biol       Date:  2020-11-11

5.  Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts.

Authors:  Torsten Lowin; Ren Tingting; Julia Zurmahr; Tim Classen; Matthias Schneider; Georg Pongratz
Journal:  Cell Death Dis       Date:  2020-09-01       Impact factor: 8.469

Review 6.  Transient Receptor Potential Vanilloid in the Brain Gliovascular Unit: Prospective Targets in Therapy.

Authors:  Huilong Luo; Xavier Declèves; Salvatore Cisternino
Journal:  Pharmaceutics       Date:  2021-03-04       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.